|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Measur- ing antiplatelet drug effects in the laboratory显示文摘 | Harrison P Frelinger AL 3rd FurmanMI | 2007 | Thromb Res2007，120，3： | 1 |
| 2 | Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump in- hibitors) , and pre-existent variability in platelet func- tion显示文摘 | Frelinger AL Bhatt DL Lee RD | 2013 | J Am Coll Cardiol2013，61，8： | 1 |
| 3 | Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms(CYP2C19,ABCB1,PON1),noncompliance,diet,smoking,co-medications(including proton pump inhibitors),and pre-existent variability in platelet function显示文摘 | FRELINGER AL BHATT DL LEE RD | 2013 | J Am Coll Cardiol2013，61，8： | 1 |
| 4 | Current options in platelet function testing显示文摘 | Miehelson AD Frelinger AL 3rd Furman MI | 2006 | Am J Cardio 12006，98，10： | 1 |
| 5 | Measuring antiplateletdrug effects in the laboratory显示文摘 | Harrison P Frelinger AL 3rd Furman MI eta 1 | 2007 | Thromb Res2007，120，： | 1 |
| 6 | Current options in platelet function testing显示文摘 | Michelson AD Frelinger AL 3rd Furman MI | 2006 | Am J Cardiol2006，98，10： | 1 |
| 7 | Current op-tions in platelet function testing显示文摘 | Michelson AD Frelinger AL Furman MI | 2006 | Am J Cardiol2006，98，10： | 1 |
| 8 | Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclo- oxygenase-l-and cyclooxygenase-2-independent path- way : a 700-patient study of aspirin resistance 显示文摘 | Frelinger AL 3rd Furman MI Linden MD | 2006 | Circulation2006，113，25： | 1 |
| 9 | Application of flow cytometry to platelet disorders 显示文摘 | Linden MD Frelinger AL Barnard MR | 2004 | Semin Thromb Hemost2004，30，5： | 1 |
| 10 | Prasugrel compared with high loading- and maintenance-dose clopid0grel in patients with planned percutaneous coronary intervention: the prasugrel in comparison to clopidogrel for inhibition of platelct activation and aggregation-thrombolysis in myocardial infarction 44 trial 显示文摘 | WIVIOTT SD TRENK D FRELINGER AL | 2007 | Circulation2007，116，25： | 1 |
| 11 | Prasugrel compared with high loading-and maintenance-dose elopidogrel in patients with planned percutaneous coronary intervention: the prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial显示文摘 | WIVIOTT SD TRENK D FRELINGER AL | 2007 | Circulation2007，116，25： | 1 |
| 12 | Dosing clopidogrel basedon CYP2C 19genotype and the effect on platelet reactivity in patients with stable cardiovascular disease 显示文摘 | MegaJL1 Hochholzer W: Frelinger AL | 2011 | Jama2011，306，： | 1 |
| 13 | Residual arachidonic acid-induced platelet activation via an adenosine diphosphatedependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance显示文摘 | Frelinger AL 3rd Furman MI Linden MD | 2006 | Circulation2006，113，25： | 1 |
| 14 | Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PEN1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function显示文摘 | Frelinger AL 3rd Bhatt DL Lee RD | 2013 | J Am Coil Cardiol2013，61，8： | 1 |
| 15 | Association of cy- clooxygenase-l-dependent and -independent platelet func- tion assays with adverse clinical outcomes in aspirin-treat- ed patients presenting for cardiac Catheterization显示文摘 | Frelinger AL Li Y Linden MD | 2009 | Cir- culation2009，120，25： | 1 |
| 16 | Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease显示文摘 | Mega JL Hochholzer W Frelinger AL 3rd | | 0，，： | 1 |
| 17 | Current options in platelet function testing显示文摘 | Michelson AD Frelinger AL III Furman MI | 2006 | Am J Cardiol2006，98，10： | 1 |
| 18 | Measuring antiplatelet drug effects in the laboratory显示文摘 | Harrison P Frelinger AL Furman MI | 2007 | Thrombosis Research2007，120，3： | 1 |
| 19 | A randomized, 2- period, crossover design study to assess the effects ofdexiansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel iu healthy volunteers 显示文摘 | Frelinger AL 3rd Lee RD Mulford DJ | 2012 | J Am Coll Cardiol2012，59，： | 1 |
| 20 | Evaluation of platelet function by flow cytonetry 显示文摘 | Michelson AD Barnard MR Krueger LA Frelinger AL Furman MI | 2000 | Methods2000，21，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员